GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock - Currency: USD
Taking everything into account, GDRX scores 6 out of 10 in our fundamental rating. GDRX was compared to 37 industry peers in the Health Care Technology industry. GDRX has only an average score on both its financial health and profitability. GDRX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make GDRX suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year GDRX was profitable.
GDRX had a positive operating cash flow in the past year.
In the past 5 years GDRX reported 4 times negative net income.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 2.20%, GDRX belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
Looking at the Return On Equity, with a value of 4.35%, GDRX belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
GDRX's Return On Invested Capital of 5.42% is amongst the best of the industry. GDRX outperforms 89.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.2% | ||
| ROE | 4.35% | ||
| ROIC | 5.42% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GDRX has a better Profit Margin (3.57%) than 86.49% of its industry peers.
In the last couple of years the Profit Margin of GDRX has declined.
GDRX's Operating Margin of 10.26% is amongst the best of the industry. GDRX outperforms 91.89% of its industry peers.
GDRX's Operating Margin has declined in the last couple of years.
GDRX's Gross Margin of 93.84% is amongst the best of the industry. GDRX outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of GDRX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.26% | ||
| PM (TTM) | 3.57% | ||
| GM | 93.84% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, GDRX has less shares outstanding
Compared to 5 years ago, GDRX has about the same amount of shares outstanding.
Compared to 1 year ago, GDRX has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.97, we must say that GDRX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GDRX (0.97) is comparable to the rest of the industry.
The Debt to FCF ratio of GDRX is 6.20, which is on the high side as it means it would take GDRX, 6.20 years of fcf income to pay off all of its debts.
GDRX has a Debt to FCF ratio of 6.20. This is in the better half of the industry: GDRX outperforms 64.86% of its industry peers.
GDRX has a Debt/Equity ratio of 0.74. This is a neutral value indicating GDRX is somewhat dependend on debt financing.
GDRX has a worse Debt to Equity ratio (0.74) than 72.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.2 | ||
| Altman-Z | 0.97 |
ROIC/WACC0.48
WACC11.25%
2.3 Liquidity
GDRX has a Current Ratio of 5.23. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 5.23, GDRX belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
GDRX has a Quick Ratio of 5.23. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.23, GDRX belongs to the best of the industry, outperforming 91.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.23 | ||
| Quick Ratio | 5.23 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.24% over the past year.
GDRX shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -24.47% yearly.
GDRX shows a small growth in Revenue. In the last year, the Revenue has grown by 4.34%.
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)17.24%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%2.57%
3.2 Future
The Earnings Per Share is expected to grow by 23.78% on average over the next years. This is a very strong growth
Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 6.00% on average per year.
EPS Next Y20.05%
EPS Next 2Y19.29%
EPS Next 3Y17.23%
EPS Next 5Y23.78%
Revenue Next Year3.37%
Revenue Next 2Y4.4%
Revenue Next 3Y5.34%
Revenue Next 5Y6%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.00, the valuation of GDRX can be described as reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 94.59% of the companies listed in the same industry.
GDRX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.91.
A Price/Forward Earnings ratio of 7.96 indicates a rather cheap valuation of GDRX.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
GDRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11 | ||
| Fwd PE | 7.96 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 86.49% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 89.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.99 | ||
| EV/EBITDA | 9.99 |
4.3 Compensation for Growth
GDRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GDRX may justify a higher PE ratio.
GDRX's earnings are expected to grow with 17.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y19.29%
EPS Next 3Y17.23%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:GDRX (5/23/2025, 9:31:44 AM)
3.74
-0.08 (-2.09%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners61.65%
Inst Owner Change-10.37%
Ins Owners10.96%
Ins Owner Change0.79%
Market Cap1.34B
Analysts75.65
Price Target6.69 (78.88%)
Short Float %4.71%
Short Ratio2.45
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.88%
Min EPS beat(2)-8.64%
Max EPS beat(2)-7.12%
EPS beat(4)0
Avg EPS beat(4)-8.74%
Min EPS beat(4)-10.15%
Max EPS beat(4)-7.12%
EPS beat(8)4
Avg EPS beat(8)0.12%
EPS beat(12)8
Avg EPS beat(12)16.11%
EPS beat(16)10
Avg EPS beat(16)12.75%
Revenue beat(2)0
Avg Revenue beat(2)-2.08%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-1.6%
Revenue beat(4)0
Avg Revenue beat(4)-2.05%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-1.6%
Revenue beat(8)0
Avg Revenue beat(8)-2.2%
Revenue beat(12)2
Avg Revenue beat(12)-1.38%
Revenue beat(16)2
Avg Revenue beat(16)-1.48%
PT rev (1m)-2.78%
PT rev (3m)-5.29%
EPS NQ rev (1m)-0.92%
EPS NQ rev (3m)-0.72%
EPS NY rev (1m)-3.53%
EPS NY rev (3m)-2.74%
Revenue NQ rev (1m)-0.24%
Revenue NQ rev (3m)-0.78%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-0.64%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11 | ||
| Fwd PE | 7.96 | ||
| P/S | 1.69 | ||
| P/FCF | 16.99 | ||
| P/OCF | 8.92 | ||
| P/B | 2.05 | ||
| P/tB | 39.89 | ||
| EV/EBITDA | 9.99 |
EPS(TTM)0.34
EY9.09%
EPS(NY)0.47
Fwd EY12.56%
FCF(TTM)0.22
FCFY5.89%
OCF(TTM)0.42
OCFY11.21%
SpS2.22
BVpS1.82
TBVpS0.09
PEG (NY)0.55
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.2% | ||
| ROE | 4.35% | ||
| ROCE | 6.87% | ||
| ROIC | 5.42% | ||
| ROICexc | 7.26% | ||
| ROICexgc | 23.92% | ||
| OM | 10.26% | ||
| PM (TTM) | 3.57% | ||
| GM | 93.84% | ||
| FCFM | 9.92% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.95%
ROICexcg growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.74 | ||
| Debt/FCF | 6.2 | ||
| Debt/EBITDA | 3.11 | ||
| Cap/Depr | 96.11% | ||
| Cap/Sales | 8.98% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 96.4% | ||
| Profit Quality | 278.06% | ||
| Current Ratio | 5.23 | ||
| Quick Ratio | 5.23 | ||
| Altman-Z | 0.97 |
F-Score8
WACC11.25%
ROIC/WACC0.48
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.24%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
EPS Next Y20.05%
EPS Next 2Y19.29%
EPS Next 3Y17.23%
EPS Next 5Y23.78%
Revenue 1Y (TTM)4.34%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%2.57%
Revenue Next Year3.37%
Revenue Next 2Y4.4%
Revenue Next 3Y5.34%
Revenue Next 5Y6%
EBIT growth 1Y368.05%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year38.3%
EBIT Next 3Y18.47%
EBIT Next 5Y13.9%
FCF growth 1Y-13.92%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y1.15%
OCF growth 3Y0.94%
OCF growth 5Y17.16%